GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.72 $2.31 Thursday, 18th Apr 2024 CTMX stock ended at $1.73. This is 1.70% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.92% from a day low at $1.72 to a day high of $1.79.
90 days $1.38 $2.86
52 weeks $1.04 $2.86

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
2021-03-19 $8.03 $8.42 $7.84 $8.27 4 837 453
2021-03-18 $8.27 $8.58 $8.00 $8.04 537 375
2021-03-17 $8.40 $8.61 $8.17 $8.46 474 742
2021-03-16 $8.70 $8.86 $8.38 $8.49 512 625
2021-03-15 $8.54 $8.80 $8.36 $8.76 748 106
2021-03-12 $8.57 $8.65 $8.39 $8.50 571 074
2021-03-11 $8.37 $8.64 $8.34 $8.63 763 657
2021-03-10 $8.38 $8.56 $8.13 $8.25 578 633
2021-03-09 $7.79 $8.30 $7.79 $8.21 585 742
2021-03-08 $7.80 $7.92 $7.48 $7.65 536 449
2021-03-05 $7.66 $7.78 $7.01 $7.78 820 054
2021-03-04 $8.19 $8.38 $7.38 $7.60 935 174
2021-03-03 $8.41 $8.50 $8.02 $8.21 744 688
2021-03-02 $8.39 $8.57 $8.13 $8.34 604 800
2021-03-01 $8.02 $8.49 $7.96 $8.45 808 491
2021-02-26 $7.86 $7.92 $7.53 $7.85 1 413 822
2021-02-25 $8.13 $8.46 $7.83 $7.86 687 819
2021-02-24 $8.01 $8.20 $7.80 $8.04 514 797
2021-02-23 $8.03 $8.28 $7.75 $8.01 956 963
2021-02-22 $8.76 $9.06 $8.48 $8.49 767 888
2021-02-19 $8.71 $8.98 $8.66 $8.92 603 650
2021-02-18 $8.44 $8.80 $8.23 $8.73 693 055
2021-02-17 $8.65 $8.76 $8.23 $8.60 603 441
2021-02-16 $9.42 $9.42 $8.59 $8.64 817 038
2021-02-12 $8.26 $9.32 $8.05 $9.00 1 935 068
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT